Frontlight ResearchEarly access
CompletedNo phase
HyperArc Registry Study
Key facts
- Who runs it
- Varian, a Siemens Healthineers Company
- Where
- Birmingham, United StatesSee the siteAlso in 3 other countries, 6 sites
- Trial code
- Status
- Completed
- People taking part
- 968 people enrolled
- Started
- 31 Mar 2022
- Ended
- 31 Mar 2025
- Type of study
- Observational
- Treatments tested
- Stereotactic radiosurgery
- Record updated
- 24 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Received or scheduled to receive treatment using the HyperArc treatment method
- Age of legal adult according to local law
- Signed informed consent form, or, informed consent waived by the local ethics board/institutional review board
Who cannot take part
- None, apart from not meeting Inclusion Criteria
Where in United States
Also in 3 other countries, 6 sites
- University of AlabamaBirmingham, United States
About the trial
What the trial wants to find out
The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.
Treatments tested
- Stereotactic radiosurgery
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 24 September 2025